{"name":"Emcure Pharmaceuticals","slug":"emcure","ticker":"EMCURE.NS","exchange":"NSE","domain":"emcure.com","description":"Emcure Pharmaceuticals Limited (Emcure) is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals.","hq":"Pune, Maharashtra, India","founded":1987,"employees":"6731","ceo":"Satish Mehta (Founder & Managing Director)","sector":"Specialty Pharma — HIV / Oncology / Cardiovascular","stockPrice":1565.4,"stockChange":10.5,"stockChangePercent":0.68,"marketCap":"$296.8B","metrics":{"revenue":88500822016,"revenueGrowth":20.4,"grossMargin":59.1,"rdSpend":0,"netIncome":8699150336,"cash":5120670208,"dividendYield":19,"peRatio":34.1,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-06-01","label":"Cipla's generic version of Lipitor patent cliff ($1.4B at risk)","drug":"Cipla's generic version of Lipitor","type":"patent_expiry","sentiment":"negative"},{"date":"2028-06-01","label":"Emcure's generic version of Nexavar patent cliff ($500M at risk)","drug":"Emcure's generic version of Nexavar","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-14","type":"deal","headline":"Emcure Pharmaceuticals acquires US-based pharmaceutical company","summary":"Emcure Pharmaceuticals has acquired a US-based pharmaceutical company, expanding its global presence and product portfolio.","drugName":"","sentiment":"positive"},{"date":"2023-08-15","type":"regulatory","headline":"Emcure Pharmaceuticals receives FDA approval for generic version of cancer treatment","summary":"Emcure Pharmaceuticals has received FDA approval for its generic version of a cancer treatment, expanding its product portfolio in the US market.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPODZLenRLbGRJcE5ydXFPNlplbjUxYTMtcnJBUlVwdHJ5WDdPaWVUNG1UNHozUE1nZ3JTeDRIMXV3TG1CcGI2ZEhteUdJRlBqYlJrMm9UMi1ISDdxOFBxYkpGM2E3cUJEZUJlTWotSVZCYzJBdFIyaDM3LW5sUEwwR2hCaUUyVXAtWkNwQW1SbkwzOHVoZkNuNzVfUGdNejRGSTFrNEoyaTFubG9ZazI1SE9FRGwxWHVTQW85S0xR?oc=5","date":"2025-11-09","type":"pipeline","source":"reuters.com","summary":"Novo Nordisk, Emcure to launch weight-loss drug under new brand in India - reuters.com","headline":"Novo Nordisk, Emcure to launch weight-loss drug under new brand in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOa1Rkb2FlWUJBOGV1LThxYUJwX1dBZTBvTl9pWnBCM0R3N2gwRzFDMXBnVW1UQTJFTlJnX2cyT0JDV2hJemg3NDdQejMyQWtSWnFwNkZVQ1VITnlOMDlnb0I4eFVvc2NWVS1oaTF0ZzBxeXpfUVQwQWtBOVBjWk9yaHNTLVM5eUZaWXNSS0ROblpnb1NlaWJTM1N4VDhramFpbjF5ZUZSVjBMcll4UXNoNUZFMkl4SUdldmN1bUJlZUtkOE43cVhjOGVoT2I0SVZYaDE0RXFaM3Rzekx6ODN2eXdYWTZzQQ?oc=5","date":"2024-10-03","type":"deal","source":"reuters.com","summary":"Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries - reuters.com","headline":"Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE9NNzlqenJOTEFGbXJOWjRsRnpwaHVDVFlZWWdpY211bzFSLVZMODdYOS1NN3hmLWhrWXFMdzVTMmsxOHZMTVJUOHlXeV9QdXgyNy1Jb05fOA?oc=5","date":"2024-09-05","type":"pipeline","source":"Yahoo Finance Singapore","summary":"AKUMS DRUGS AND PHARMA L (AKUMS.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"AKUMS DRUGS AND PHARMA L (AKUMS.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNdkE0Sm81SmsxSjJLWU9Pd3A0OUpPTHZpeExYblplOXgzR3hNcDlPQ01GYjhOOV9Ga2w5aENFeTlHZTdrWGxWV1BBWVlSMU8xVXl3eEdhYnBPZlQ2UHV5UDQ0SGtDQXFpQUtnUWU0cDhkYnNTTmozdGpaNnlxeEJBX2VSSndrY3Q5bXVpMmNST2UybHFPYWw3UVU4N3VsdWdDeE4zWlRfYW5IUjBmOGVV?oc=5","date":"2024-07-05","type":"pipeline","source":"reuters.com","summary":"Bain-backed Emcure Pharma's $234 mln India IPO draws $11 bln in bids - reuters.com","headline":"Bain-backed Emcure Pharma's $234 mln India IPO draws $11 bln in bids","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPZFZNMG96Q09YU2NtUTlXMzFQU1JXNmRkQlh4STlRekVpOFRSN0dKQjdFZnA4MXVlR0U1NHc3RGZHWVhhSHk3VUtka2Z0N0pxZ0ZDQ0Y0Mm01d2VKRl80dUl6RE5XTUtucm56VWZPa3JOcnFlT1k5YldHS2RpWnVKcjFpcWpZQW1Ld2hYLWE5aXdrUFBkOS1jaldfejd5SWdtLUtaRHdB0gGrAUFVX3lxTE9zUHNfa0xCOVRPb2VGWER6WXdkeGphZDg3UkhIb1JEMGNuTlBSUXFsR3dnR01YOVFOUGRIQ3ZCODZKNkFHdlktcmR1ZVFEVEdwcUNwZGVmN3gyQlgtYzJZTjMtTTdsNC1XbllMWkprR254YlVPNEVqbDFOX2hDZzBvSC1mQ1VUeC1NaUhhMnBId2lJVWh0LUxraUVIRHNESVVEaHpKUEU4VFJ5aw?oc=5","date":"2023-05-15","type":"pipeline","source":"Express Pharma","summary":"Emcure Pharma launches 750 mg injectable variant of Ferric Carboxymaltose - Express Pharma","headline":"Emcure Pharma launches 750 mg injectable variant of Ferric Carboxymaltose","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE10QW4yYzNIYllPcnAyZ1NjUTk4cDBhTTdzalB0NTZRemV2RnFNakRTYUUxYzlVMkY4dGJkSGVQWDNkRjdhWVNpZ0h6ZUs0anpMY29BNkgyNA?oc=5","date":"2017-08-20","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Lupin Limited (LUPIN.BO) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Lupin Limited (LUPIN.BO) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5UbFlSTVU4d0ViZVVIOE5uT2NVdWxTUVc5TVdrS19HRk9LaExTZUJ2RG1KbDQxLTZETlQydUlfR2s0SnBNM2tQckpNMGEyeEphRHo2LXJGWV8yeE1tN2c?oc=5","date":"2017-08-08","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Ajanta Pharma Limited (AJANTPHARM.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Ajanta Pharma Limited (AJANTPHARM.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE81M09rdXk0VGNvb09nU053X0Y2ZS1hcGdSOU80dk9vZzVqLUFNc2ZfX3ZwZzUxMGV4aU83ZXVINmhudkNOZXJxbHhtbjdPMTg2aVkwYzExWE9XOEo1?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Shilpa Medicare Limited (SHILPAMED.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Shilpa Medicare Limited (SHILPAMED.NS) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"Cipla's generic version of Lipitor","drugSlug":"atorvastatin","patentNumber":"","type":"Patent Cliff","expiryDate":"2027-06-01","territory":"US","annualRevenue":1400000000},{"drugName":"Emcure's generic version of Nexavar","drugSlug":"sorafenib","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":500000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Cipla","Sun Pharma","Dr. Reddy's Laboratories"],"therapeuticFocus":["HIV","Oncology","Cardiovascular"],"financials":null,"yahoo":{"currentPrice":1565.4,"previousClose":1554.9,"fiftyTwoWeekHigh":1671.8,"fiftyTwoWeekLow":900,"fiftyTwoWeekRange":"900.0 - 1671.8","fiftyDayAverage":1496.38,"twoHundredDayAverage":1412.27,"beta":0,"enterpriseValue":307678969856,"forwardPE":25.8,"priceToBook":6.25,"priceToSales":3.35,"enterpriseToRevenue":3.48,"enterpriseToEbitda":18.5,"pegRatio":0,"ebitda":16629990400,"ebitdaMargin":18.8,"freeCashflow":0,"operatingCashflow":0,"totalDebt":16592180224,"debtToEquity":34,"currentRatio":0,"returnOnAssets":0,"returnOnEquity":0,"analystRating":"1.3 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":6,"targetMeanPrice":1794.83,"targetHighPrice":1932,"targetLowPrice":1620,"dividendRate":3,"payoutRatio":0.07,"fiveYearAvgDividendYield":0,"exDividendDate":1755129600,"insiderHeldPercent":81.7,"institutionHeldPercent":5.1,"sharesOutstanding":189589547,"floatShares":41616821,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":45.87,"epsForward":60.7,"revenuePerShare":466.98,"bookValue":250.31,"officers":[{"age":74,"name":"Mr. Satish Ramanlal Mehta","title":"CEO, MD & Executive Director"},{"age":43,"name":"Mr. Samit Satish Mehta","title":"President of Operations & Whole-Time Director"},{"age":73,"name":"Dr. Mukund Keshao Gurjar","title":"Chief Scientific Officer & Whole-Time Director"},{"age":62,"name":"Mr. Sunil Rajanikant Mehta","title":"Executive Director of Projects & Whole-Time Director"},{"age":48,"name":"Ms. Namita Vikas Thapar","title":"Executive Director of India Business & Whole-Time Director"},{"age":null,"name":"Mr. Tajuddin Sabir Shaikh","title":"Chief Financial Officer"},{"age":null,"name":"Ms. Amruta Jana Yangalwar","title":"Company Secretary & Compliance Officer"},{"age":null,"name":"Mr. Naveen  Soni","title":"Director of Corporate Communications & Public Relations"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.emcure.com","phone":"91 20 3507 0033"}}